Page last updated: 2024-12-08

n-(2-(1-maleimidyl)ethyl)-7-(diethylamino)coumarin-3-carboxamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(2-(1-maleimidyl)ethyl)-7-(diethylamino)coumarin-3-carboxamide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID158349
SCHEMBL ID1908058
MeSH IDM0234014

Synonyms (18)

Synonym
mdcc fluorophore
7-(diethylamino)-n-[2-(2,5-dioxopyrrol-1-yl)ethyl]-2-oxochromene-3-carboxamide
156571-46-9
7-diethylamino-3-[n-(2-maleimidoethyl)carbamoyl]coumarin
SCHEMBL1908058
n-(2-(1-maleimidyl)ethyl)-7-(diethylamino)coumarin-3-carboxamide
2h-1-benzopyran-3-carboxamide, 7-(diethylmino)-n-(2-(2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)ethyl)-2-oxo-
mdcc
FT-0621395
J-100132
7-diethylamino-3-[n-(4-maleimidoethyl)carbamoyl]coumarin
7-(diethylamino)-n-(2-(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)ethyl)-2-oxo-2h-chromene-3-carboxamide
DTXSID80166097
7-diethylamino-3-[n-(2-maleimidoethyl)carbamoyl]coumarin, bioreagent, suitable for fluorescence, >=97.0% (hplc)
7-diethylamino-3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin
2h-1-benzopyran-3-carboxamide, 7-(diethylamino)-n-[2-(2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)ethyl]-2-oxo-
7-diethylamino-3-((((2-maleimidyl)ethyl)amino) carbonyl)coumarin
PD195424
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (29.17)18.2507
2000's10 (41.67)29.6817
2010's6 (25.00)24.3611
2020's1 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.32 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]